Arthneeti
TC

Thirumalai Chemicals Ltd

Q1 FY27

Thirumalai Chemicals Q1 FY27 investor presentation: Revenue & Margins

Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.

Price₹142
Market cap₹1.7K Cr
Updated16 Oct 2026
Read5 min read

Based on Thirumalai Chemicals Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentationreports, not management guidance.

The short version

Revenue/Sales Figures for Q1 FY27: - Consolidated Revenue from Operations: INR 547 Cr (22% YoY increase from INR 450 Cr in Q1 FY26) - Standalone Revenue from Operations: INR 331 Cr (25% YoY decrease from INR 446 Cr in Q1 FY26) - Consolidated Total Income: INR 550 Cr (22% YoY increase from INR 452 Cr Q1 FY26) - Standalone Total Income: INR 340 Cr (25% YoY decrease from INR 453 Cr Q1 FY26) - Volume Figures: - 16,839.4 KL rainwater harvested/reused (no period comparison) - Phthalic Anhydride reactor at OOSB, Malaysia, achieved 95% capacity utilization (Q1 FY27) - No explicit quarterly volume figures detailed for sales. Q1 FY27 EBITDA: - Consolidated: INR 36 Cr, up from INR -25 Cr in Q1 FY26 (246% YoY increase) - Standalone: INR 51 Cr, up from INR 7 Cr in Q1 FY26 (644% YoY increase) - Operating Margin (EBITDA %): - Consolidated: 7% in Q1 FY27 vs.

From Thirumalai Chemicals Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • Revenue/Sales Figures for Q1 FY27:
  • Consolidated Revenue from Operations: INR 547 Cr (22% YoY increase from INR 450 Cr in Q1 FY26)
  • Standalone Revenue from Operations: INR 331 Cr (25% YoY decrease from INR 446 Cr in Q1 FY26)
  • Consolidated Total Income: INR 550 Cr (22% YoY increase from INR 452 Cr Q1 FY26)
  • Standalone Total Income: INR 340 Cr (25% YoY decrease from INR 453 Cr Q1 FY26)
  • Volume Figures:
  • 16,839.4 KL rainwater harvested/reused (no period comparison)
  • Phthalic Anhydride reactor at OOSB, Malaysia, achieved 95% capacity utilization (Q1 FY27)
  • No explicit quarterly volume figures detailed for sales.
  • Explicit Outlook for Revenue/Volumes:
  • US facility commencement expected to provide competitive advantage soon.
  • Planned shutdown (~510 KTA Chinese OX capacity) to keep PAn prices firm, supporting realizations.
  • Demand growth visible in Paint, UPR, CPC segments.

2 more points from Thirumalai Chemicals Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Thirumalai Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • USA Facility Expansion:
  • Building a 40 KTPA Maleic Anhydride (MAn) capacity plant in New Martinsville, West Virginia.
  • Facility located within an established chemical complex.
  • Strategic access to American & European markets.
  • Leverages abundant and competitively priced feedstock (n-butane).
  • Provides a fully integrated plant with self-generated energy.
  • Focus on increasing the portfolio of food ingredients (Malic Acid & Fumaric Acid).
  • Status: Ongoing capex at TCL Specialties LLC (USA operation).
  • Manufacturing Capacities:
  • India Operations:
  • Ranipet: PAn 165 KTPA + derivatives.
  • Dahej: PAn 24 KTPA, FAc 10 KTPA.

2 more points from Thirumalai Chemicals Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Fundraising & Capital Structure

See what Thirumalai Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided investor presentation from Thirumalai Chemicals Ltd. does not explicitly mention any figures or details related to order book, order inflow, or pending orders. The presentation focuses mainly on financial highlights, ESG metrics, operational performance, market conditions, future outlook, and key business factors but does not disclose specific data on: - Order book status - Order inflow volumes - Pending or backlog orders Therefore, based solely on the information in this presentation, no details about order book, order inflow, or pending orders are reported.

Thirumalai Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹416 Cr, net loss ₹47 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Thirumalai Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Neochem Bio Solutions Ltd (Q1 FY27)

    Revenue from Operations in H2 FY26: ₹64.9 crore . Key investor presentation takeaways from Neochem Bio's Q1 FY27 investor presentation — and how it ranks agains

  • Prasol Chemicals Ltd (Q1 FY27)

    However, the company indicates strong demand with orders leading to capacity utilization rising from 12% to over 60% at the Mahad plant. Key concall takeaways…

  • Fine Organic Industries Ltd (Q1 FY27)

    Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

  • Chemfab Alka. (Q1 FY27)

    Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key concall takeaways from Chemfab Alkalis Ltd's Q1…

Compare:vs Solar Industriesvs SRF Ltdvs Linde India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Thirumalai Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Thirumalai Chemicals Ltd Q1 FY27 results?

Revenue/Sales Figures for Q1 FY27: - Consolidated Revenue from Operations: INR 547 Cr (22% YoY increase from INR 450 Cr in Q1 FY26) - Standalone Revenue from Operations: INR 331 Cr (25% YoY decrease from INR 446 Cr in Q1 FY26) - Consolidated Total Income: INR 550 Cr (22% YoY increase from INR 452 Cr Q1 FY26) - Standalone Total Income: INR 340 Cr (25% YoY decrease from INR 453 Cr Q1 FY26) - Volume Figures: - 16,839.4 KL rainwater harvested/reused (no period comparison) - Phthalic Anhydride reactor at OOSB, Malaysia, achieved 95% capacity utilization (Q1 FY27) - No explicit quarterly volume figures detailed for sales. Q1 FY27 EBITDA: - Consolidated: INR 36 Cr, up from INR -25 Cr in Q1 FY26 (246% YoY increase) - Standalone: INR 51 Cr, up from INR 7 Cr in Q1 FY26 (644% YoY increase) - Operating Margin (EBITDA %): - Consolidated: 7% in Q1 FY27 vs.

What is Thirumalai Chemicals Ltd share price analysis?

Thirumalai Chemicals Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹1,715 Cr. Investors should review the full earnings analysis for detailed insights.

Is Thirumalai Chemicals Ltd planning capital expenditure?

USA Facility Expansion: - Building a 40 KTPA Maleic Anhydride (MAn) capacity plant in New Martinsville, West Virginia.

Keep Thirumalai Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.